In addition, METTL3 inhibits hepatic insulin sensitivity via N6-methylation of FASN (fatty acid synthetase) mRNA and promoting fatty acid metabolism, which eventually results in the development of T2D [69]. This evidence concerns the gene METTL3 and type 2 diabetes mellitus.